Kaswan Michael 4/A
4/A · Orchestra BioMed Holdings, Inc. · Filed May 19, 2023
Insider Transaction Report
Form 4/AAmended
Kaswan Michael
Chief Financial Officer
Transactions
- Award
Nonstatutory Stock Option (Right to Buy)
2023-01-26+192,566→ 192,566 totalExercise: $10.00Exp: 2032-08-17→ Common Stock (192,566 underlying)
Footnotes (3)
- [F1]On January 30, 2023, the Reporting Person filed a Form 4 which inadvertently (i) misstated the expiration date of one class of nonstatutory stock options ("NSOs") and (ii) misstated the vesting schedule for such NSOs. In accordance with Instruction 9(b) to Form 4, this amendment is filed solely to (i) correct the incorrect expiration date in Table II, Column 6 to August 17, 2032, and (ii) correct the incorrect vesting schedule set forth in the footnote corresponding to such NSOs, which is reproduced in this amendment with the correct vesting schedule; as provided in that instruction, the remainder of the information in the original filing is not restated in this amendment, and no other amendment is made to the original filing.
- [F2]The NSOs have vested and will vest in equal installments over a three-year period on a quarterly basis on the last day of each quarter, starting with September 30, 2022, subject to the Reporting Person's continuous service through such dates. The grant date is August 18, 2022.
- [F3]Received in the Business Combination in exchange for a nonstatutory stock option to acquire 414,120 shares of Legacy Orchestra Common Stock for $4.65 per share.